Plastic fantastic: Schwann cells and repair of the peripheral nervous system

Stem Cells Translational Medicine

Volumn 2, Issue 8, 2013, Pages 553-557

  Kim, Haesun A ^a   Mindos, Thomas ^b   Parkinson, David B ^b  

^a RUTGERS UNIVERSITY   (United States)

^b PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMIN; BRAIN DERIVED NEUROTROPHIC FACTOR; EPHRIN B2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELIN PROTEIN; NERVE CELL ADHESION MOLECULE; NEU DIFFERENTIATION FACTOR; NOTCH RECEPTOR; PROTEIN C JUN; PROTEIN RET; RAF PROTEIN; RAS PROTEIN; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; LOW DRUG DOSE; NERVE CELL; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE INJURY; NERVE REGENERATION; NERVE TRANSECTION; NONHUMAN; PROTEIN EXPRESSION; REINNERVATION; REMYELINIZATION; SCHWANN CELL; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84880957631     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0011     Document Type: Article

References (36)

1. Arthur-Farraj PJ, Latouche M, Wilton DK et al. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 2012;75:633-647.
2. Harrisingh MC, Perez-Nadales E, Parkinson DB et al. The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J 2004;23:3061-3071.
3. Yang DP, Kim J, Syed N et al. p38 MAPK activation promotes denervated Schwann cell phenotype and functions as a negative regulator of Schwann cell differentiation and myelination. J Neurosci 2012;32:7158-7168.
4. Zrouri H, Le Goascogne C, LiWWet al. The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve. Eur J Neurosci 2004;20:1811-1818.
5. Myers RR, Sekiguchi Y, Kikuchi S et al. Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp Neurol 2003;184: 606-614.
6. Guertin AD, Zhang DP, Mak KS et al. Microanatomy of axon/glial signaling during Wallerian degeneration. J Neurosci 2005;25:3478-3487.
7. Napoli I, Noon LA, Ribeiro S et al. A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 2012;73: 729-742.
8. Tapinos N, Ohnishi M, Rambukkana A. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat Med 2006;12:961-966.
9. Woodhoo A, Alonso MB, Droggiti A et al. Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. Nat Neurosci 2009;12:839-847.
10. Syed N, Reddy K, Yang DP et al. Soluble neuregulin-1 has bifunctional, concentrationdependent effects on Schwann cell myelination. J Neurosci 2010;30:6122-6131.
11. Newbern JM, Li X, Shoemaker SE et al. Specific functions for ERK/MAPK signaling during PNS development. Neuron 2011;69:91-105.
12. Grossmann KS, Wende H, Paul FE et al. The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development. Proc Natl Acad Sci USA 2009;106:16704-16709.
13. Ishii A, Furusho M, Bansal R. Sustained activation of ERK1/2 MAPK in oligodendrocytes and Schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. J Neurosci 2013;33:175-186.
14. Fragoso G, Robertson J, Athlan E et al. Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination. Exp Neurol 2003;183:34-46.
15. Raivich G, Bohatschek M, Da Costa C et al. The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 2004;43:57-67.
16. Parkinson DB, Bhaskaran A, Arthur-Farraj P et al. c-Jun is a negative regulator of myelination. J Cell Biol 2008;181:625-637.
17. Fontana X, Hristova M, Da Costa C et al. c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling. J Cell Biol 2012;198:127-141.
18. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
19. Le N, Nagarajan R, Wang JY et al. Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci USA 2005;102:2596-2601.
20. Parrinello S, Napoli I, Ribeiro S et al. EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell 2010;143:145-155.
21. Webber CA, Christie KJ, Cheng C et al. Schwann cells direct peripheral nerve regeneration through the Netrin-1 receptors, Dcc and Unc5H2. Glia 2011;59:1503-1517.
22. Wang Y, Teng HL, Huang ZH. Repulsive migration of Schwann cells induced by Slit-2 through Ca(2_)-dependent RhoA-Myosin signaling. Glia 2013;61:710-723.
23. Maro GS, Vermeren M, Voiculescu O et al. Neural crest boundary cap cells constitute a source of neuronal and glial cells of the PNS. Nat Neurosci 2004;7:930-938.
24. Zujovic V, Thibaud J, Bachelin C et al. Boundary cap cells are peripheral nervous system stem cells that can be redirected into central nervous system lineages. Proc Natl Acad Sci USA 2011;108:10714-10719.
25. Mathon NF, Malcolm DS, Harrisingh MC et al. Lack of replicative senescence in normal rodent glia. Science 2001;291:872-875.
26. Nataf V, Le Douarin NM. Induction of melanogenesis by tetradecanoylphorbol-13 acetate and endothelin 3 in embryonic avian peripheral nerve cultures. Pigment Cell Res 2000;13:172-178.
27. Rizvi TA, Huang Y, Sidani A et al. A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve. J Neurosci 2002;22:9831-9840.
28. Masaki T, Qu J, Cholewa-Waclaw J et al. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell 2013;152:51-67.
29. Zochodne DW. The challenges and beauty of peripheral nerve regrowth. J Peripher Nerv Syst 2012;17:1-18.
30. Fu SY, Gordon T. Contributing factors to poor functional recovery after delayed nerve repair: Prolonged axotomy. J Neurosci 1995; 15:3876-3885.
31. Fu SY, Gordon T. Contributing factors to poor functional recovery after delayed nerve repair: Prolonged denervation. J Neurosci 1995;15:3886-3895.
32. Dahlin LB. Techniques of peripheral nerve repair. Scand J Surg 2008;97:310-316.
33. Allodi I, Udina E, Navarro X. Specificity of peripheral nerve regeneration: Interactions at the axon level. Prog Neurobiol 2012;98:16-37.
34. Parrinello S, Lloyd AC. Neurofibroma development in NF1: Insights into tumour initiation. Trends Cell Biol 2009;19:395-403.
35. Ammoun S, Ristic N, Matthies C et al. Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244. Neurobiol Dis 2010;37:141-146.
36. AmmounS, Flaiz C, RisticNet al. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signalregulated kinase pathway in human schwannoma. Cancer Res 2008;68:5236-5245.